Clinical Trial Update: Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP [Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 3 long-term treatment study of MRA for rheumatoid arthritis (Study MRA213JP) sponsored by Chugai Pharmaceutical.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MRA (MRA)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED